Publications by authors named "A Chunharas"
Clinical practice guidelines for the diagnosis and management of atopic dermatitis.
Asian Pac J Allergy Immunol
September 2021
Atopic dermatitis (AD), a chronic, relapsing dermatitis, is characterized by dry and pruritus skin in patients with a personal or family history of atopy. It affects up to 20% of children and 1-3% of adults in most countries worldwide, and leads to significant treatment costs and morbidity. These guidelines are developed in accordance with evidence-based publications and expert opinions.
View Article and Find Full Text PDFClinical practice guideline for diagnosis and management of urticaria.
Asian Pac J Allergy Immunol
September 2016
Article Synopsis
- * A new guideline developed by various Thai medical associations provides evidence-based recommendations and algorithms to help physicians manage urticaria in both adults and children, emphasizing the importance of accurate diagnosis and treatment strategies.
- * First-line treatment for chronic spontaneous urticaria involves non-sedating H1-antihistamines, with options to increase dosage if necessary; alternative treatments like anti-IgE are available but may be costly, and lifestyle modifications are also suggested to reduce skin sensitivity.
Propranolol, 2 mg/kg/day, is effective in the treatment of infantile hemangioma. We report the response to propranolol in infants with hemangioma at a dose of 1 mg/kg/day. Sixteen infants with newly diagnosed infantile hemangioma were given propranolol at a dose titrated from 0.
View Article and Find Full Text PDFRandomized, double-blind, split-side, comparison study of moisturizer containing licochalcone A and 1% hydrocortisone in the treatment of childhood atopic dermatitis.
J Med Assoc Thai
September 2013
Background: Atopic dermatitis (AD) is a common chronic inflammatory skin lesion in children. Topical corticosteroid is the mainstay of treatment.
Objective: To compare the efficacy of moisturizer containing licochalcone A (LicA) and 1% hydrocortisone for the treatment of mild to moderate childhood AD.